Artesunate potentiates poly (ADP-ribose) polymerase inhibitor efficacy in ovarian cancer through RAD51-mediated homologous recombination repair impairment.
- DOI
- 10.1016/j.phymed.2026.158420
- Published
- 2026 Nov
- Container
- Phytomedicine : international journal of phytotherapy and phytopharmacology
- Publisher
- Not recorded
- Open access
- unknown
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1016/j.phymed.2026.158420,
title = {Artesunate potentiates poly (ADP-ribose) polymerase inhibitor efficacy in ovarian cancer through RAD51-mediated homologous recombination repair impairment.},
author = {Zhou S and Xue L and Li G and Huang L and Gu J and Wang X and Li H and Liu Z and Li F and Jiang J and Li N},
year = {2026},
journal = {Phytomedicine : international journal of phytotherapy and phytopharmacology},
doi = {10.1016/j.phymed.2026.158420},
url = {https://doi.org/10.1016/j.phymed.2026.158420}
}RIS
TY - JOUR TI - Artesunate potentiates poly (ADP-ribose) polymerase inhibitor efficacy in ovarian cancer through RAD51-mediated homologous recombination repair impairment. AU - Zhou S AU - Xue L AU - Li G AU - Huang L AU - Gu J AU - Wang X AU - Li H AU - Liu Z AU - Li F AU - Jiang J AU - Li N PY - 2026 JO - Phytomedicine : international journal of phytotherapy and phytopharmacology DO - 10.1016/j.phymed.2026.158420 UR - https://doi.org/10.1016/j.phymed.2026.158420 ER -
APA
S, Z., L, X., G, L., L, H., J, G., X, W., H, L., Z, L., F, L., J, J., & N, L. (2026). Artesunate potentiates poly (ADP-ribose) polymerase inhibitor efficacy in ovarian cancer through RAD51-mediated homologous recombination repair impairment.. Phytomedicine : international journal of phytotherapy and phytopharmacology. https://doi.org/10.1016/j.phymed.2026.158420
Source records
- pubmed · retrieved 2026-09-27T06:43:08.579Z